Expand Manufacturing Capacity
- Prague and Krems facilities to produce Influenza vaccine
- 14 million doses by 2004
- 28 million doses by 2005
- 42 million doses by 2006
- Krems facility flexible to produce other vaccines as well
Expected Vaccines Capacity
* Acambis is a contract manufacturer, not a Baxter owned facility